In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.

Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott’s leading life sciences lawyers. Beginning October 20, we’ll bring you a series of three pre-Symposium programs focused on today’s most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.

iBIO Members save on registration with the code: LSDSMEM20

PROGRAM DETAILS

Virtual Life Sciences Dealmaking Symposium
Tuesday, November 17, 2020
8:00 am – 2:00 pm EST
*Networking platform will be open from 8:00 am – 6:00 pm EST*

AGENDA:

8:00 – 9:45 am.         Pre-event Networking

9:30 – 9:35 am.        Welcome Remarks
Krist Werling, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery

9:35 – 10:00 am.      Michelle McMurry-Heath Keynote
President and CEO, Biotechnology Innovation Organization

10:00 – 10:40 am.    M&A Outlook: Expect the Unexpected
Moderator: Byron Kalogerou, Partner, McDermott Will & Emery
Kristie Bradford, Director, Intellectual Property, IBM Corporation
Dennis Crowley, Senior Vice President, Business Development & Licensing, Baxter
Patrice McNicoll, Co-head of Investment Banking, B. Riley Financial

10:40 – 11:10 am.    Sight Unseen: Cross-border Collaboration Goes Virtual
Moderator: Emmanuelle Trombe, Partner, McDermott Will & Emery
Frederic Scaerou, Lead Director, Business Development and Licensing, Servier Pharmaceuticals
Vivek Ramaswamy, CEO, Roivant Sciences
Rich Smith, Partner, McDermott Will & Emery

11:10 – 11:15 am     Bio Break

11:15 – 11:45 am.    Speed vs. Safety: Innovating with Urgency in Diagnostics & Vaccines
Moderator: Brian Malkin, Partner, McDermott Will & Emery
Steve Bossone, Senior Vice President, Chief Patent Counsel, Alnylam
Alan Wright, Chief Medical Officer, Roche Diagnostics
Sarah Columbia, Partner, McDermott Will & Emery
Michael Ryan, Partner, McDermott Will & Emery

11:45 am – 12:15 pm.    Digital Health Takes Center Stage: Will It Be The Hottest Sector for Dealmaking?
Moderator: Stephen Bernstein, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery
Kathy Bergsteinsson, Managing Director, Morgan Stanley
Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund
Rene Quashie, Vice President, Policy and Regulatory Affairs, Digital Health, Consumer Technology Association
Jennifer Geetter, Partner, McDermott Will & Emery

12:15 – 12:45 pm.    Racial Justice in the Start-up Sector: the McDermott RISE Program
Moderator: Vernessa Pollard, Chair, FDA Practice, McDermott Will & Emery
Nathan Pelzer, CEO, Clinify Health
Kwame Ulmer, Founder, MedTech Color
Marshall Jackson, Partner, McDermott Will & Emery

12:45 – 1:30p.    Scott Gottlieb Keynote
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS

1:30 – 2:00 pm.    Post-event Networking